South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes

Regulations by 2FIRSTS.ai
Aug.14.2024
South Africa Reboots Tobacco Control Act: Planning to Unify the Package of Vapes
South Africa's Tobacco Control and Electronic Delivery Systems Bill has been reintroduced by parliament, aiming to enhance public health measures.

According to BusinessTech's report on August 13th, the South African "Tobacco Products Control and Electronic Delivery Systems Bill" has been revived by Parliament after lapsing at the end of the previous government's term, and has now entered the further processing stage. The bill was first introduced in December 2022 in the National Assembly and has now been included in the agenda of the seventh government.


According to reports, the proposed bill aims to strengthen public health protection measures by aligning current smoking control legislation with the requirements of the World Health Organization's Framework Convention on Tobacco Control. The legislation under consideration would regulate the sale, advertising, and use of tobacco products and electronic delivery systems. Specific provisions include:


Strengthening the standards for the processing, manufacturing, and importing of products and related products.


Regulate advertising of tobacco products and electronic delivery systems.


Standardizing the packaging and appearance of tobacco and electronic delivery system products.


Smoking is prohibited in all indoor public areas and "designated outdoor areas.


Prohibition of cigarette vending machines.


Mandatory adoption of "simplified packaging with graphic health warnings";


It is prohibited to display tobacco products and electronic delivery systems at retail locations.


The reintroduction of this bill has provoked mixed reactions. Dr. Sharon Nyatsanza of the National Coalition Against Smoking (NCAS) stated that this legislation is an important step towards promoting a healthier society. She said:


By aligning domestic legislation with global standards, a strong tobacco control policy is crucial in reducing the burden of non-communicable diseases in South Africa and supporting the sustainable implementation of national health insurance. The measures in this bill will help reduce tobacco use, exposure to secondhand smoke, and youth smoking.


Dr. Catherine Egbe, head of the Global Adult Tobacco Survey in South Africa (GATS-SA), emphasized the need to pass the bill as soon as possible.


According to GATS-SA data, 29.4% of individuals aged 15 and over, totaling 12.7 million people, are using tobacco, facing serious health risks such as cancer, cardiovascular diseases, and respiratory diseases. The phenomenon of adolescents using e-cigarettes is also on the rise, raising concerns about nicotine addiction and long-term health effects, especially on the developing brains of young people.


Dr. Egbe stated that the proposed measures in the bill are an effective strategy to reduce tobacco and e-cigarette use, and should be urgently implemented, along with an increase in taxes.


Our government has access to all the research that can support every evidence-based measure in the bill and should not be influenced by misleading information.


It has been reported that the National Assembly Health Committee, a former parliamentary subcommittee, had called for written submissions on the bill. A nationwide public hearing subsequently ended in December 2023. Throughout this process, media statements from the committee largely indicated broad principle support for the bill's health-related objectives. However, there are still many pressing issues to be addressed at the operational level. These include:


The likelihood of an increase in illicit tobacco product trade.


The potential decrease in tax revenue from the production and sale of legal tobacco products and electronic delivery systems;


There is insufficient attention given to the impact on small and medium-sized informal traders, especially retailers of single cigarette sales.


Monitoring and enforcement capabilities are inadequate.


Despite the prevalence of the cigarette market in South Africa, illegal trade is rapidly growing. Opponents of the legislation believe that such laws could further fuel the development of the illegal market.


The South African Legal Academy (SA Legal Academy) mentioned:


Given these issues, it is currently unclear how the new National Assembly Health Committee will address them.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15